We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Neon Therapeutics Inc | NASDAQ:NTGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.07 | 3.00 | 3.46 | 0 | 01:00:00 |
|
Delaware
|
|
001-38551
|
|
46-3915846
|
(State or other jurisdiction
|
|
(Commission
|
|
(I.R.S. Employer
|
of incorporation)
|
|
File Number)
|
|
Identification No.)
|
Title of each class
|
Trade Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.001 par value per share
|
NTGN
|
The Nasdaq Global Select Market
|
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|||
19,696,223
|
|
|
73,646
|
|
|
593,984
|
|
|
Neon Therapeutics, Inc.
|
|
|
|
|
Date: May 5, 2020
|
By:
|
/s/ Jolie M. Siegel
|
|
Name:
|
Jolie M. Siegel
|
|
Title:
|
Vice President, General Counsel and Secretary
|
1 Year Neon Therapeutics Chart |
1 Month Neon Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions